MIRA Pharmaceuticals | 10-Q: Quarterly report

SEC announcementMay 13 15:36 · Announcements

323 drugs, hurry up! America is facing the biggest “drug shortage” in history...

The US now seems to be facing an unprecedented “drug shortage”...

cls.cnApr 15 01:37

MIRA Pharmaceuticals Sees Positive Trial Results for Ketamir-2

By Chris Wack MIRA Pharmaceuticals said it saw positive results in its trial for Ketamir-2, a novel oral ketamine analog that could potentially deliver ultra-rapid antidepressant effects. The pre-cl

WSJApr 2 07:17

Mira Pharmaceuticals Highlights Preclinical Ketamir-2 Updates; Says Is Hopeful Results Will Enable Co. To File An NDA With FDA By End Of This Year

Mira Pharmaceuticals Highlights Preclinical Ketamir-2 Updates; Says Is Hopeful Results Will Enable Co. To File An NDA With FDA By End Of This Year

BenzingaApr 2 07:04

Mira Pharmaceuticals Q4 EPS $(0.19) Beats $(0.23) Estimate

Mira Pharmaceuticals (NASDAQ:MIRA) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.23) by 17.39 percent.

BenzingaApr 2 06:54

GOEV, CHEK and MESO Among Pre-market Losers

Seeking AlphaMar 27 07:28